David R Epstein
Director, AgomAb Therapeutics NV; Director, Tempus AI
Bought, 12 months
$0.2M
Sold, 12 months
$0.1M
Companies
2
Latest trade
Oct 21, 2026
Companies
AgomAb Therapeutics NVDirector +$0.2M Tempus AIDirector −$0.1MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.

